Metabolic syndrome and cognitive decline in the elderly: A systematic review

PLoS ONE

Volumn 13, Issue 3, 2018, Pages

  Assuncao, Naima ^a,b   Sudo, Felipe Kenji ^a,c   Drummond, Claudia ^a,b   De Felice, Fernanda Guarino ^b   Mattos, Paulo ^a,b  

^a D OR INSTITUTE FOR RESEARCH AND EDUCATION IDOR   (Brazil)

^b FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c PONTIFICAL CATHOLIC UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER;

AGED; COGNITIVE DEFECT; COMPLICATION; DEMENTIA; FACTUAL DATABASE; HUMAN; HYPERGLYCEMIA; METABOLIC SYNDROME X; METABOLISM; RISK FACTOR;

AGED; BIOMARKERS; COGNITIVE DYSFUNCTION; DATABASES, FACTUAL; DEMENTIA; HUMANS; HYPERGLYCEMIA; METABOLIC SYNDROME; RISK FACTORS;

EID: 85044533285     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0194990     Document Type: Article

References (62)

1. Mazza A, Pessina AC, Zamboni S, Casiglia E. Prognostic role of metabolic syndrome in the elderly is not greater than the sum of its components. Aging health. 2010; 6(2): 217-228. https://doi.org/10.2217/AHE.10.9
2. Reaven GM. Banting lecture. Role of insulin resistance in human disease. Diabetes, 1998; 37: 1595-1607. https://doi.org/10.2337/diab.37.12.1595
3. Balkau B, Charles MA, Drivsholm T, Borch-Johnsen K, Wareham N, Yudkin JS et al. Frequency of the WHO metabolic syndrome in European cohorts, and an alternative definition of an insulin resistance syndrome. Diabetes Metab. 2002; 28(5):364-76. DM-11-2002-28-5-1262-3636-101019-ART3. PMID: 12461473
4. Ravaglia G, Forti P, Maioli F, Bastagli L, Chiappelli M, Montesi F et al. Metabolic Syndrome: prevalence and prediction of mortality in elderly individuals. Diabetes Care. 2006; 29(11):2471-6. https://doi.org/10.2337/dc06-0282 PMID: 17065687
5. Kjeldsen S, Feldman RD, Lisheng L, Mourad JJ, Chiang CE, Zhang W et al. Updated National and International Hypertension Guidelines: A Review of Current Recommendations. Drugs. 2014; 74(17), 2033-2051. https://doi.org/10.1007/s40265-014-0306-5 PMID: 25315030
6. Denys K, Cankurtaran M, Janssens W, Petrovic M. Metabolic syndrome in the elderly: an overview of the evidence. Acta Clin Belg. 2009; 64-1. https://doi.org/10.1179/acb.2009.006 PMID: 19317238
7. Leritz EC, McGlinchey RE, Kellison I, Rudolph JL, Milberg WP. Cardiovascular Disease Risk Factors and Cognition in the Elderly. Current cardiovascular risk reports. 2011; 5(5):407-412. https://doi.org/10.1007/s12170-011-0189-x PMID: 22199992
8. Jellinger KA. The enigma of vascular cognitive disorder and vascular dementia. Acta Neuropathol. 2007; 113(4):349-88. https://doi.org/10.1007/s00401-006-0185-2 PMID: 17285295
9. Hachinski V. Vascular Dementia: A Radical Redefinition. Dement Geriatr Cogn Dis. 1994; 5:130-132. https://doi.org/10.1159/000106709
10. Masellis M, Sherborn K, Neto PR, Sadovnick DA, Hsiung GYR, Black SE et al. Early-onset dementias: diagnostic and etiological considerations. Alzheimers Res Ther. 2013; 5(Suppl 1), S7. https://doi.org/10.1186/alzrt197 PMID: 24565469
11. Wells G, Shea B, O'Connell D, et al. Newcastle-Ottawa quality assessment scale cohort studies. Avaliable on: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp. Assessed on January 2nd 2018.
12. The PLOS Medicine Editors. Observational Studies: Getting Clear about Transparency. Plos One. 2014; 11(8): e1001711. PMID: 10.1371/journal.pmed.1001711.
13. Dik MG, Jonker C, Comijs HC, Deeg DJ, Kok A, Yaffe K et al. Contribution of metabolic syndrome components to cognition in older individuals. Diabetes Care, 2007; 30(10):2655-60. https://doi.org/10.2337/dc06-1190 PMID: 17563341
14. Viscogliosi G, Andreozzi P, Chiriac IM, Cipriani E, Servello A, Ettorre E, Marigliano V. Screening Cognition in the Elderly with Metabolic Syndrome. Metab Syndr Relat Disord. 2012; 10(5):358-362. https://doi.org/10.1089/met.2012.0043 PMID: 22784389
15. Viscogliosi G, Chiriac IM, Andreozzi P, Ettorre E. Executive dysfunction assessed by Clock-Drawing Test in older non-demented subjects with metabolic syndrome is not mediated by white matter lesions. Psychiatry Clin Neurosci. 2015; 69: 620-629. https://doi.org/10.1111/pcn.12296 PMID: 25781474
16. Viscogliosi G, Chiriacm IM, Andreozzi P, Ettorre E. The Metabolic Syndrome Predicts Longitudinal Changes in Clock Drawing Test Performance in Older Nondemented Hypertensive Individuals. Am J Geriatr Psychiatry. 2016; 24(5):359-363. https://doi.org/10.1016/j.jagp.2015.09.001 PMID: 26803584
17. Shigaeff N, Jacinto AF, Franco FGM, Chiochetta G, Cendoroglo MS, Cítero VA Cognitive assessment in an elderly population with metabolic syndrome in Brazil. Dement Neuropsychol. 2013; 7(2):206-209. https://doi.org/10.1590/S1980-57642013DN70200011 PMID: 29213841
18. Watts AS, Loskutova N, Burns JM, Johnson DK. Metabolic Syndrome and Cognitive Decline in Early Alzheimer's Disease and Healthy Older Adults. J Alzheimers Dis. 2013; 35(2), 253-265. http://doi.org/10.3233/JAD-121168. https://doi.org/10.3233/JAD-121168 PMID: 23388170
19. Ghosh A, Biswas AK, Banerjee A. A study on cognitive decline with respect to metabolic syndrome and inflammation in elderly Indians. Neurol India. 2015; 63(4):537-41. https://doi.org/10.4103/0028-3886. 162037 PMID: 26238888
20. Hishikawa N, Fukui Y, Sato K, Kono S, Yamashita T, Ohta Y et al. Cognitive and affective functions in Alzheimer's disease patients with metabolic syndrome. Eur J Neurol. 2016; 23(2):339-45. https://doi.org/10.1111/ene.12845 PMID: 26493280
21. Van Den Berg E, Biessels GJ, de Craen AJ, Gussekloo J, Westendorp RG. The metabolic syndrome is associated with decelerated cognitive decline in the oldest old. Neurology. 2007; 69:979-985. https://doi.org/10.1212/01.wnl.0000271381.30143.75 PMID: 17785666
22. Roriz-Cruz M, Rosset I, Wada T, Sakagami T, Ishine M, De SáRoriz-Filho J et al. Cognitive impairment and frontal-subcortical geriatric syndrome are associated with metabolic syndrome in a stroke-free population. Neurobiol Aging. 2007; 28: 1723-1736. https://doi.org/10.1016/j.neurobiolaging.2006.07.013 PMID: 16962212
23. Laudisio A, Marzetti E, Pagano F, Cocchi A, Franceschi C, Bernabei R et al. Association of metabolic syndrome with cognitive function: The role of sex and age. Clin Nutr. 2008; 27:747-754. https://doi.org/10.1016/j.clnu.2008.07.001 PMID: 18715681
24. Lee KS, Jang Y, Chung YK, Chung JH, Oh BH, Hong CH. Relationship between the diagnostic components of metabolic syndrome (MS) and cognition by ApoE genotype in the elderly. Arch Gerontol Geriatr. 2010; 50: 69-72. https://doi.org/10.1016/j.archger.2009.01.014 PMID: 19243844
25. Raffaitin C, Féart C, Le Goff M, Amieva H, Helmer C, Akbaraly TN et al. Metabolic syndrome and cognitive decline in French elders. The Three-City Study. Neurology, 2011; 76:518-525. https://doi.org/10.1212/WNL.0b013e31820b7656 PMID: 21288982
26. Harrison SL, Stephan BC, Siervo M, Granic A, Davies K, Wesnes KA et al. Is there an association between metabolic syndrome and cognitive function in very old adults? The Newcastle 85+ Study. J Am Geriatr Soc. 2015; 63(4):667-75. https://doi.org/10.1111/jgs.13358 PMID: 25850570
27. Viscogliosi G, Donfrancesco C, Palmieri L, Giampaoli S. The metabolic syndrome and 10-year cognitive and functional decline in very old men. A population-based study. Arch Gerontol Geriatr. 2017; 70: 62-66. http://dx.doi.org/10.1016/j.archger.2016.12.008. https://doi.org/10.1016/j.archger.2016.12.008 PMID: 28076836
28. Liu CL, Lin MH, Peng LN, Chen LK, Su CT, Liu LK et al. Late-life metabolic syndrome prevents cognitive decline among older men aged 75 years and over: one-year prospective cohort study. J Nutr Health Aging. 2013; 17(6): 523-26. https://doi.org/10.1007/s12603-013-0010-2 PMID: 23732548
29. Katsumata Y, Todoriki H, Higashiuesato Y, Yasura S, Willcox DC, Ohya Y et al. Metabolic Syndrome and Cognitive Decline Among the Oldest Old in Okinawa: In Search of a Mechanism. The KOCOA Project. J Gerontol A Biol Sci Med Sci. 2012; 67A(2), 126-134. https://doi.org/10.1093/gerona/glr189 PMID: 22016359
30. Komulainen P, Lakka TA, Kivipelto M, Hassinen M, Helkala EL, Haapala I et al. Metabolic Syndrome and Cognitive Function: A Population-Based Follow-Up Study in Elderly Women. Dement Geriatr Cogn Dis. 2006; 23:29-34. https://doi.org/10.1159/000096636 PMID: 17068394
31. Del Brutto OH, Mera RM, Zambrano M. Metabolic syndrome correlates poorly with cognitive performance in stroke-free community-dwelling older adults: a population-based, cross-sectional study in rural Ecuador. Aging Clin Exp Res. 2016; 28(2):321-5. https://doi.org/10.1007/s40520-015-0404-6 PMID: 26142624
32. Yaffe K, Haan M, Blackwell T, Cherkasova E, Whitmer RA, West N. Metabolic Syndrome and Cognitive Decline in Elderly Latinos: Findings from the Sacramento Area Latino Study of Aging Study. J Am Geriatr Soc. 2007; 55(5):758-62. https://doi.org/10.1111/j.1532-5415.2007.01139.x PMID: 17493197
33. Yaffe K, Kanaya A, Lindquist K, Simonsick EM, Harris T, Shorr RI et al. The Metabolic Syndrome, Inflammation, and Risk of Cognitive Decline. JAMA. 2004; 292:2237-2242. https://doi.org/10.1001/jama.292.18.2237 PMID: 15536110
34. Rouch I, Trombert B, Kossowsky MP, Laurent B, Celle S, Ntougou Assoumou G, Roche F, Barthelemy JC. Metabolic Syndrome is Associated with Poor Memory and Executive Performance in Elderly Community Residents: The PROOF Study. American J Geriatr Psychiatry, 2014; 22(11):1096-104. https://doi.org/10.1016/j.jagp.2014.01.005 PMID: 24534523
35. Viticchi G, Falsetti L, Buratti L, Luzzi S, Bartolini M, Acciarri MC et al. Int J Geriatr Psychiatry, 2015; 30: 1164-1170. https://doi.org/10.1002/gps.4269 PMID: 25754252
36. Tsai CK, Kao TW, Lee JT, Wu CJ, Hueng DY, Liang CS et al. Increased risk of cognitive impairment in patients with components of metabolic syndrome. Medicine. 2016; 95(36), e4791. https://doi.org/10.1097/MD.0000000000004791 PMID: 27603384
37. Liu M, He Y, Jiang B, Wu L, Wang J, Yang S et al. Association between metabolic syndrome and mild cognitive impairment and its age difference in a Chinese community elderly population. Clin Endocrinol. 2015; 82: 844-853. https://doi.org/10.1111/cen.12734 PMID: 25641226
38. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report. Circulation. 2002; 106:3143. Assessed in June 21st, 2017. Available from: http://circ.ahajournals.org/content/106/25/3143.long. PMID: 12485966
39. Alberti KG, Zimmet P, Shaw J. Metabolic syndrome-a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2016; 23(5):469-80. https://doi.org/10.1111/j.1464-5491.2006.01858.x PMID: 16681555
40. Matsuzawa Y. Metabolic syndrome-definition and diagnostic criteria in Japan. J Atheroscler Thromb; 2005; 12: 301. http://doi.org/10.5551/jat.12.301. PMID: 16394611
41. Teng EL, Chui HC. The Modified Mini-Mental State (3MS) examination. J Clin Psych, 1987; 48(8):314-8. https://doi.org/10.1007/springerreference-183334
42. Ketema EB, Kibret KT. Correlation of fasting and postprandial plasma glucose with HbA1c in assessing glycemic control; systematic review and meta-analysis. Arch Public Health. 2015; 73, 43. http://doi.org/10.1186/s13690-015-0088-6 https://doi.org/10.1186/s13690-015-0088-6 PMID: 26413295
43. Danese E, Montagnana M, Nouvenne A, Lippin G. Advantages and Pitfalls of Fructosamine and Glycated Albumin in the Diagnosis and Treatment of Diabetes. J Diabetes Sci Technol. 2015; 9(2), 169-176. http://doi.org/10.1177/1932296814567227. https://doi.org/10.1177/1932296814567227 PMID: 25591856
44. Booth ML, Hunter C, Gore CJ, Bauman A, Owen N. The relationship between body mass index and waist circumference: implications for estimates of the population prevalence of overweight. Int J Obes Relat Metab Disord. 2000; 24(8):1058-1061. PMID: 10951546
45. Costa A, Bak T, Caffarra P, Caltagirone C, Ceccaldi M, Collette F et al. The need for harmonization and innovation of neuropsychological assessment in neurodegenerative dementias in Europe: consensus document of the Joint Program for Neurodegenerative Diseases Working Group. Alzheimers Res Ther. 2017; 9, 27. https://doi.org/10.1186/s13195-017-0254-x PMID: 28412978
46. Daffner KR, Gale SA, Barrett AM, Boeve BF, Chatterjee A, Coslett H B et al. Improving clinical cognitive testing: Report of the AAN Behavioral Neurology Section Workgroup. Neurology. 2015; 85(10), 910-918. http://doi.org/10.1212/WNL.0000000000001763. https://doi.org/10.1212/WNL. 0000000000001763 PMID: 26163433
47. De Felice FG, Ferreira ST. Inflammation, Defective Insulin Signaling, and Mitochondrial Dysfunction as Common Molecular Denominators Connecting Type 2 Diabetes to Alzheimer Disease. Diabetes. 2014; 63 (7): 2262-2272. https://doi.org/10.2337/db13-1954 https://doi.org/10.2337/db13-1954 PMID: 24931033
48. Tortelli R, Lozupone M, Guerra V, Barulli MR, Imbimbo BP, Capozzo R et al. Midlife Metabolic Profile and the Risk of Late-Life Cognitive Decline. J Alzheimers Dis. 2017; 59(1):121-130. https://doi.org/10.3233/JAD-170153 PMID: 28582862
49. Ekblad LL, Rinne JO, Puukka P, Laine H, Ahtiluoto S, Sulkava R et al. Insulin Resistance Predicts Cognitive Decline: An 11-Year Follow-up of a Nationally Representative Adult Population Sample. Diabetes Care. 2017; 40(6):751-758. https://doi.org/10.2337/dc16-2001 PMID: 28381479
50. Han BH, Sutin D, Williamson JD, Davis BR, Piller LB, Pervin H et al. Effect of Statin Treatment vs Usual Care on Primary Cardiovascular Prevention Among Older Adults The ALLHAT-LLT Randomized Clinical Trial. JAMA Intern Med. 2017; 177(7):955-965. https://doi.org/10.1001/jamainternmed.2017.1442 PMID: 28531241
51. Corrada MM, Hayden KM, Paganini-Hill A, Bullain SS, DeMoss J, Aguirre C et al. Age of onset of hypertension and risk of dementia in the oldest-old: The 90+ Study. Alzheimers Dement. 2017; 13(2):103-110. https://doi.org/10.1016/j.jalz.2016.09.007 PMID: 28108119
52. Kim S, Kim Y, Park SM. Body Mass Index and Decline of Cognitive Function. PLoS ONE. 2016; 11(2), e0148908. https://doi.org/10.1371/journal.pone.0148908 PMID: 26867138
53. Coin A, Veronese N, De Rui M, Mosele M, Bolzetta F, Girardi A, et al. Nutritional predictors of cognitive impairment severity in demented elderly patients: The key role of BMI. J Nutr Health Aging. 2012; 16 (6):553-6. https://doi.org/10.1007/s12603-012-0052-x PMID: 22659996
54. Sergi G, Perissinotto E, Pisent C, Buja A, Maggi S, Coin A, et al. An adequate threshold for body mass index to detect underweight condition in elderly persons: the Italian Longitudinal Study on Aging (ILSA). J Gerontol A Biol Sci Med Sci, 2005; 60(7):866-71. https://doi.org/10.1093/gerona/60.7.866 PMID: 16079209
55. Dasgupta K, Quinn RR, Zarnke KB, Rabi DM, Ravani P, Daskalopoulou SS. The 2014 Canadian Hypertension Education Program (CHEP) recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention and treatment of hypertension. Can J Cardiol. 2014; 30:485-501. https://doi.org/10.1016/j.cjca.2014.02.002 PMID: 24786438
56. Mancia G, De Backer G, Dominiczak A, Cifkova R, Fagard R, Germano G et al. 2007 Guidelines for the management of arterial hypertension: The Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2007; 28:1462-536. https://doi.org/10.1093/eurheartj/ehm236 PMID: 17562668
57. National Institute for Health and Care Excellence. Hypertension: clinical management of primary hypertension in adults (Clinical guideline 127, 2016). http://guidance.nice.org.uk/CG127. Accessed in July 10th 2017.
58. Doiron M, Dupré N, Langlois M, Provencher P, Simard M. Smoking history is associated to cognitive impairment in Parkinson's disease. Aging & Ment Health. 2017; 21(3):322-326. https://doi.org/10.1080/13607863.2015.1090393 PMID: 26416159
59. Emamian F, Khazaie H, Tahmasian M, Leschziner GD, Morrell MJ, Hsiung G. et al. The Association Between Obstructive Sleep Apnea and Alzheimer's Disease: A Meta-Analysis Perspective. Front Aging Neurosci. 2016; 8, 78. https://doi.org/10.3389/fnagi.2016.00078 PMID: 27148046
60. Greenberg MS, Tanev K, Marin MF, Pitman RK. Stress, PTSD, and dementia. Alzheimers Dement. 2014; 10(3 Suppl):S155-65. https://doi.org/10.1016/j.jalz.2014.04.008 PMID: 24924667
61. Lövdén M, Xu W, Wang HX. Lifestyle change and the prevention of cognitive decline and dementia: what is the evidence? Curr Opin Psychiatry. 2013; 26(3):239-43. https://doi.org/10.1097/YCO. 0b013e32835f4135 PMID: 23493129
62. Siervo M, Harrison SL, Jagger C, Robinson L, Stephan BC. Metabolic syndrome and longitudinal changes in cognitive function: a systematic review and meta-analysis. J Alzheimers Dis. 2014; 41 (1):151-61. https://doi.org/10.3233/JAD-132279 PMID: 24577475